Breast Conservation Therapy versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose The aim of this study is to compare the treatment outcomes of breast conserving surgery (BCS) plus radiotherapy (RT) versus mastectomy for patients with pT1-2N1 triple-negative breast cancer (TNBC). Materials and Methods Using two multicenter retrospective studies on breast cancer, a pooled analysis was performed among 320 patients with pT1-2N1 TNBC. All patients who underwent BCS (n=212) received whole breast RT with or without regional nodal RT, while none who underwent mastectomy (n=108) received it. All patients received taxane-based adjuvant chemotherapy. The median follow-up periods were 65 months in the BCS+RT group, and 74 months in the mastectomy group. Results The median age of all patients was 48 years (range, 24 to 70 years). Mastectomy group had more patients with multiple tumors (p < 0.001), no lymphovascular invasion (p=0.001), higher number of involved lymph node (p=0.028), and higher nodal ratio 0.2 (p=0.037). Other characteristics were not significantly different between the two groups. The 5-year locoregional recurrence-free, disease-free, and overall survival rates of BCS+RT group versus mastectomy group were 94.6% versus 87.7%, 89.5% versus 80.4%, and 95.0% versus 87.8%, respectively, and the differences were statistically significant after adjusting for covariates (p=0.010, p=0.006, and p=0.005, respectively). Conclusion In pT1-2N1 TNBC, breast conservation therapy achieved better locoregional recurrencefree, disease-free, and overall survival rates compared with mastectomy.
Abstract
Purpose The aim of this study is to compare the treatment outcomes of breast conserving surgery (BCS) plus radiotherapy (RT) versus mastectomy for patients with pT1-2N1 triple-negative breast cancer (TNBC). Materials and Methods Using two multicenter retrospective studies on breast cancer, a pooled analysis was performed among 320 patients with pT1-2N1 TNBC. All patients who underwent BCS (n=212) received whole breast RT with or without regional nodal RT, while none who underwent mastectomy (n=108) received it. All patients received taxane-based adjuvant chemotherapy. The median follow-up periods were 65 months in the BCS+RT group, and 74 months in the mastectomy group. Results The median age of all patients was 48 years (range, 24 to 70 years). Mastectomy group had more patients with multiple tumors (p < 0.001), no lymphovascular invasion (p=0.001), higher number of involved lymph node (p=0.028), and higher nodal ratio 0.2 (p=0.037). Other characteristics were not significantly different between the two groups. The 5-year locoregional recurrence-free, disease-free, and overall survival rates of BCS+RT group versus mastectomy group were 94.6% versus 87.7%, 89.5% versus 80.4%, and 95.0% versus 87.8%, respectively, and the differences were statistically significant after adjusting for covariates (p=0.010, p=0.006, and p=0.005, respectively). Conclusion In pT1-2N1 TNBC, breast conservation therapy achieved better locoregional recurrencefree, disease-free, and overall survival rates compared with mastectomy.
참고문헌 (29)
- Lowery AJ, "Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype", Breast Cancer Res Treat, 133, pp.831~841 (2012)
- Ihemelandu CU, "Treatment and survival outcome for molecular breast cancer subtypes in black women", Ann Surg, 247, pp.463~469 (2008)
- Parker CC, "Is breast conservation therapy a viable option for patients with triplereceptor negative breast cancer?", Surgery, 148, pp.386~391 (2010)
- Adkins FC, "Triple-negative breast cancer is not a contraindication for breast conservation", Ann Surg Oncol, 18, pp.3164~3173 (2011)
- 안기정, "Lymphovascular invasion as a negative prognostic factor for triple-negative breast cancer after surgery", Radiation oncology journal, 35(4), pp.332~339 (2017), 대한방사선종양학회
- Wang J, "Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer: a meta-analysis", Surg Oncol, 22, pp.247~255 (2013)
- Hwang ES, "Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status", Cancer, 119, pp.1402~1411 (2013)
- Agarwal S, "Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer", JAMA Surg, 149, pp.267~274 (2014)
- Hartmann-Johnsen OJ, "Survival is better after breast conserving therapy than mastectomy for early stage breast cancer: a registry-based follow-up study of Norwegian women primary operated between 1998 and 2008", Ann Surg Oncol, 22, pp.3836~3845 (2015)
- van Maaren MC, "10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study", Lancet Oncol, 17, pp.1158~1170 (2016)
- 강진규, "The clinical utilization of radiation therapy in Korea between 2009 and 2013", Radiation oncology journal, 34(2), pp.88~95 (2016), 대한방사선종양학회
- Lee JA, "Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival", Breast Cancer Res Treat, 123, pp.177~187 (2010)
- 김해영, "Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline Plus Taxane-Based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study", Cancer Research and Treatment, 49(4), pp.970~980 (2017), 대한암학회
- 박혜진, "Incorporating Risk Factors to Identify the Indication of Post-mastectomy Radiotherapy in N1 Breast Cancer Treated with Optimal Systemic Therapy: A Multicenter Analysis in Korea (KROG 14-23)", Cancer Research and Treatment, 49(3), pp.739~747 (2017), 대한암학회
- Fisher B, "Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer", N Engl J Med, 347, pp.1233~1241 (2002)
- Veronesi U, "Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer", N Engl J Med, 347, pp.1227~1232 (2002)
- Abdulkarim BS, "Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy", J Clin Oncol, 29, pp.2852~2858 (2011)
- Zumsteg ZS, "Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer", Ann Surg Oncol, 20, pp.3469~3476 (2013)
- Kindts I, "Omitting radiation therapy in women with triple-negative breast cancer leads to worse breast cancer-specific survival", Breast, 32, pp.18~25 (2017)
- Bhoo-Pathy N, "Prognostic role of adjuvant radiotherapy in triple-negative breast cancer: a historical cohort study", Int J Cancer, 137, pp.2504~2512 (2015)
- Mamounas EP, "The importance of systemic therapy in minimizing local recurrence after breast-conserving surgery: the NSABP experience", J Surg Oncol, 110, pp.45~50 (2014)
- Poortmans P, "Postmastectomy radiation in breast cancer with one to three involved lymph nodes: ending the debate", Lancet, 383, pp.2104~2106 (2014)
- Recht A, "Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology focused guideline update", J Clin Oncol, 34, pp.4431~4442 (2016)
- Truong PT, "Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy", Int J Radiat Oncol Biol Phys, 61, pp.1337~1347 (2005)
- Tendulkar RD, "Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy", Int J Radiat Oncol Biol Phys, 83, pp.577~581 (2012)
- McBride A, "Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment", Int J Radiat Oncol Biol Phys, 89, pp.392~398 (2014)
- Whelan TJ, "Regional nodal irradiation in early-stage breast cancer", N Engl J Med, 373, pp.307~316 (2015)
- Poortmans PM, "Internal mammary and medial supraclavicular irradiation in breast cancer", N Engl J Med, 373, pp.317~327 (2015)
- van Roozendaal LM, "Three-dimensional breast radiotherapy and the elective radiation dose at the sentinel lymph nodes site in breast cancer", Ann Surg Oncol, 22, pp.3824~3830 (2015)